(Q44611394)

4 December 2017

title

Is FDG-PET a useful tool in clinical practice for diagnosing corticobasal ganglionic degeneration? (English)

1 reference

4 December 2017

Is FDG‐PET a useful tool in clinical practice for diagnosing corticobasal ganglionic degeneration? (English)

1 reference

19 March 2024

1 reference

19 March 2024

author name string

Ilse M. F. Coulier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14534923

19 March 2024

Joeke J. de Vries

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14534923

19 March 2024

Klaus L. Leenders

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14534923

19 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

4 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmds.10498

1 reference

https://onlinelibrary.wiley.com/doi/full/10.1002/mds.10498

19 March 2024

1 reference

19 March 2024

1 reference

4 December 2017

volume

18

1 reference

4 December 2017

issue

10

1 reference

4 December 2017

page(s)

1175-1178

1 reference

Pathologic heterogeneity in clinically diagnosed corticobasal degeneration

4 December 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FMDS.10498

Corticodentatonigral Degeneration With Neuronal Achromasia

21 January 2018

2

1 reference

Corticobasal degeneration

19 March 2024

4

1 reference

Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration

19 March 2024

5

1 reference

Morphological overlap between corticobasal degeneration and Pick's disease: a clinicopathological report

19 March 2024

6

1 reference

Corticobasal degeneration: neuropathologic and clinical heterogeneity

19 March 2024

7

1 reference

Clinical presentation and pharmacological therapy in corticobasal degeneration

19 March 2024

8

1 reference

Corticobasal degeneration. A clinical study of 36 cases.

19 March 2024

9

1 reference

Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study

19 March 2024

12

1 reference

Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET.

19 March 2024

14

1 reference

PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration

19 March 2024

15

1 reference

Cerebral glucose metabolism in corticobasal degeneration: comparison with progressive supranuclear palsy and normal controls

19 March 2024

16

1 reference

The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography

19 March 2024

18

1 reference

Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography

19 March 2024

19

1 reference

Contribution of PET studies in diagnosis of corticobasal degeneration

19 March 2024

20

1 reference

Features of regional cerebral glucose metabolism abnormality in corticobasal degeneration.

19 March 2024

21

1 reference

Comparison of brain perfusion in corticobasal degeneration and Alzheimer's disease

19 March 2024

22

1 reference

The nigrostriatal dopaminergic system in familial early onset parkinsonism with parkin mutations

19 March 2024

23

1 reference

19 March 2024

Identifiers

DOI

10.1002/MDS.10498

1 reference

4 December 2017

1 reference